Sabrina Sehbai – Trademark Portfolio

Entity Type: 01

Sabrina Sehbai holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include JOIN HANDS. The owner is based in Erlenbach.

Weinbergstrasse 35

Erlenbach 8703 , CH

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Sabrina Sehbai's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

39
Transportation & Storage (1 filing)

Transport; packaging and storage of goods; travel arrangement

Frequently Asked Questions

How many trademarks does Sabrina Sehbai have?

Sabrina Sehbai has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Sabrina Sehbai file in?

Sabrina Sehbai files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 39 (Transportation & Storage). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Sabrina Sehbai's most well-known trademarks?

Sabrina Sehbai's registered trademark portfolio includes well-known marks such as JOIN HANDS. These are among 1 currently registered trademark in the portfolio.

What is Sabrina Sehbai's trademark registration success rate?

Sabrina Sehbai has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.